Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 61

1. Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorder.

ERDOĞAN A., TOPCUOĞLU M., COŞKUN M. N., CİNEMRE B., KULAKSIZOĞLU B., KULOĞLU M. M.
Human psychopharmacology , cilt.37, sa.2, 2022 (SCI-Expanded) identifier identifier identifier

2. Sociodemographic and clinical characteristics of patients admitted to an addiction center

ERDOĞAN A., Dilcen H. Y., CİNEMRE B., KULAKSIZOĞLU B., İNAN D., Kuloglu M. M.
JOURNAL OF SUBSTANCE USE , cilt.27, sa.3, ss.321-327, 2022 (SSCI) Sürdürülebilir Kalkınma identifier identifier

3. Follow-up of serum naltrexone levels after naltrexone implant in opioid use disorder

KULAKSIZOĞLU B., ERDOĞAN A., CİNEMRE B., TOPCUOĞLU M., COŞKUN M. N., Ozdemir M., et al.
Heroin Addiction and Related Clinical Problems , cilt.23, sa.3, ss.23-28, 2021 (SSCI) Sürdürülebilir Kalkınma identifier identifier

4. Distribution of Hepatitis C Virus (HCV) Genotypes Among Intravenous Drug and Non-Drug User Patients

Erman Daloglu A., PARKAN Ö. M., ERDOĞAN A., Peker B. O., Can Sarinoglu R., SAĞLIK İ., et al.
MIKROBIYOLOJI BULTENI , cilt.55, sa.1, ss.30-40, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

5. Comparison of oral naltrexone and naltrexone implant treatment in alcohol use disorders Alkol kullanım bozukluğunda oral naltrekson ve naltrekson implant tedavisinin karşılaştırılması

CİNEMRE B., ERDOĞAN A., KULAKSIZOĞLU B., METİN Ö., Kuloglu M. M.
Anadolu Psikiyatri Dergisi , cilt.21, sa.5, ss.477-482, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

6. Turkish adaptation of Kessler Psychological Distress Scale: validity and reliability study

Altun Y., Ozen M., Kuloglu M. M.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.20, ss.23-31, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

7. Evaluation of Subclinical Left Ventricular Systolic Dysfunction in Chronic Asymptomatic Alcoholics by Speckle Tracking Echocardiography

KÜÇÜK M., Oncel C. R., Yjldjrjm A. B., Canan F., Kuloglu M. M.
BIOMED RESEARCH INTERNATIONAL , cilt.2017, 2017 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

8. Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

akyol E. S., albayrak Y., beyazyüz M., aksoy N., Kuloglu M. M., Hashimoto K.
NEUROPSYCHIATRIC DISEASE AND TREATMENT , cilt.11, ss.865-872, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

9. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia

Albayrak Y., Beyazyuz M., Beyazyuz E., Kuloglu M. M.
NORDIC JOURNAL OF PSYCHIATRY , cilt.68, sa.5, ss.341-346, 2014 (SCI-Expanded) identifier identifier identifier

10. Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

Yanik M. E., ERFAN G., Albayrak Y., Aydin M., Kulac M., Kuloglu M. M.
NEUROPSYCHIATRIC DISEASE AND TREATMENT , cilt.10, ss.2361-2367, 2014 (SCI-Expanded) Creative Commons License identifier identifier identifier

11. A Catatonic Schizophrenia Case Treated Effectively with Aripiprazole

Albayrak Y., Kuloglu M. M.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.23, sa.3, ss.257-260, 2013 (SCI-Expanded) identifier identifier

12. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study

ALBAYRAK Y., Unsal C., BEYAZYÜZ M., Unal A., Kuloglu M. M.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.45, ss.144-149, 2013 (SCI-Expanded) identifier identifier identifier

13. Temperament and Character Traits and Alexithymia in Patients with Multiple Sclerosis

Kuloglu M. M., Saglam S., korkmaz S., sağlam S., Gurok M. G., Karti Ustun S., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.50, sa.1, ss.34-39, 2013 (SCI-Expanded) identifier identifier

14. Psychotic Disorder due to Withdrawal of Barbexaclone

Kuloglu M. M., korkmaz S., sağlam S., Atmaca M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.50, sa.1, ss.87-88, 2013 (SCI-Expanded) identifier identifier

15. Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

Unsal C., Albayrak Y., Albayrak N., Kuloglu M., Hashimoto K.
NEUROPSYCHIATRIC DISEASE AND TREATMENT , cilt.9, ss.1545-1552, 2013 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

16. Olanzapine Induced Hair Loss: A Case Report

Kuloglu M. M., korkmaz S., kılıç N., Saglam S., Gurok M. G., Atmaca M.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.22, sa.4, ss.362-365, 2012 (SCI-Expanded) identifier identifier

17. Visual hallucinations associated with bupropion use: a case report

korkmaz S., Kuloglu M. M., sağlam S., Atmaca M.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.22, sa.2, ss.187-189, 2012 (SCI-Expanded) identifier identifier

18. A Case of Borderline Erotomania Accompanying Obsessive Compulsive Disorder and Psychogenic Polydipsia: Case Report

korkmaz S., Kuloglu M. M., bahçeci B., Atmaca M.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.32, sa.1, ss.271-275, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

19. Galactorrhea During Duloxetine Treatment: A Case Report

korkmaz S., Kuloglu M. M., ışık U., sağlam S., Atmaca M.
TURK PSIKIYATRI DERGISI , cilt.22, sa.3, ss.200-201, 2011 (SSCI) identifier identifier identifier

20. Olfactory reference syndrome treated with quetiapine: a case

Atmaca M., korkmaz S., namlı M. N., korkmaz H., Kuloglu M. M.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.21, sa.3, ss.246-248, 2011 (SCI-Expanded) Creative Commons License identifier identifier

21. Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature

Kuloglu M. M., ekinci O., albayrak Y., çayköylü A.
ARCHIVES OF WOMENS MENTAL HEALTH , cilt.13, sa.5, ss.443-447, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

22. Phenomenology of Delusions and Hallucinations in Patients with Schizophrenia

Gecici O., Kuloglu M., Guler O., Ozbulut O., Kurt E., Onen S., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.20, sa.3, ss.204-212, 2010 (SCI-Expanded) identifier identifier

23. Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone

Kuloglu M. M., ekinci o., çayköylü a.
JOURNAL OF PSYCHOPHARMACOLOGY , cilt.24, sa.4, ss.627-628, 2010 (SCI-Expanded) identifier identifier identifier

24. Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use

Kuloglu M. M., çayköylü a., ekinci o., bayındırlı d., vural g., deniz o.
JOURNAL OF PSYCHOPHARMACOLOGY , cilt.24, sa.4, ss.623-624, 2010 (SCI-Expanded) identifier identifier identifier

25. Aripiprazole-induced rabbit syndrome: a case report

çayköylü a., ekinci o., Kuloglu M. M., deniz o.
JOURNAL OF PSYCHOPHARMACOLOGY , cilt.24, sa.3, ss.429-431, 2010 (SCI-Expanded) identifier identifier identifier

26. A case study of Neuro-psycho-Behcet's Syndrome presenting with psychotic attack

deniz O., çayköylü A., Vural G., albayrak Y., temel S., aydın I., et al.
CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.111, sa.10, ss.877-879, 2009 (SCI-Expanded) identifier identifier identifier

27. Obsessive Symptoms Associated with Lamotrigine use in a Patient with Bipolar II Disorder

Kuloglu M. M., ekinci O., yılmaz E., çayköylü A.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.19, sa.4, ss.414-416, 2009 (SCI-Expanded) identifier identifier

28. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report

Kuloglu M. M., çayköylü a., ekinci o., yılmaz e.
JOURNAL OF PSYCHOPHARMACOLOGY , cilt.23, sa.8, ss.1001-1003, 2009 (SCI-Expanded) identifier identifier identifier

29. Arnold-Chiari I malformation association with generalized anxiety disorder: A case report

çayköylü A., ekinci O., albayrak Y., Kuloglu M. M., deniz O.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.32, sa.6, ss.1613-1614, 2008 (SCI-Expanded) identifier identifier identifier

30. A left temporal lobe arachnoid cyst in a patient with schizophrenia-like psychosis: A case report

Kuloglu M. M., çayköylü A., yılmaz E., ekinci O.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.32, sa.5, ss.1353-1354, 2008 (SCI-Expanded) identifier identifier identifier

31. Improvement from treatment-resistant schizoaffective disorder, manic type after stopping heavy caffeine intake: A case report

çayköylü A., ekinci O., Kuloglu M. M.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.32, sa.5, ss.1349-1350, 2008 (SCI-Expanded) identifier identifier identifier

32. Antioxidant enzyme and malondialdehyde levels in patients with social phobia

Atmaca M., Kuloglu M. M., Tezca E., Ustundag B.
PSYCHIATRY RESEARCH , cilt.159, sa.1-2, ss.95-100, 2008 (SCI-Expanded) identifier identifier identifier

33. Serum leptin and cholesterol values in violent and non-violent suicide attempters

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B.
PSYCHIATRY RESEARCH , cilt.158, sa.1, ss.87-91, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

34. The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia

Atmaca M., Tezcan E., Kuloglu M. M., Ustundag B., Kirtas O.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.59, sa.6, ss.652-656, 2005 (SCI-Expanded) Creative Commons License identifier identifier identifier

35. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder

Atmaca M., Tezcan E., Kuloglu M. M., Kirtas O., Ustundag B.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.59, sa.5, ss.616-620, 2005 (SCI-Expanded) identifier identifier identifier

36. Plasma nitrate values in patients with obsessive-compulsive disorder

Atmaca M., Tezcan E., Kuloglu M. M., Ustundag B.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.59, sa.5, ss.621-623, 2005 (SCI-Expanded) identifier identifier identifier

37. Serum leptin levels in obsessive-compulsive disorder

Atmaca M., Tezcan E., Kuloglu M. M., Ustundag B.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.59, sa.2, ss.189-193, 2005 (SCI-Expanded) Creative Commons License identifier identifier identifier

38. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions

Atmaca M., Kuloglu M. M., Tezcan E.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH , cilt.17, sa.2, ss.201-203, 2005 (SCI-Expanded) Creative Commons License identifier identifier identifier

39. Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment

Atmaca M., Tezcan E., Kuloglu M. M., Ustundag B., Tunckol H.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.254, sa.4, ss.231-235, 2004 (SCI-Expanded) identifier identifier identifier

40. Nizatidine for the treatment of patients with quetiapine-induced weight gain

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B., Kilic N.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.19, sa.1, ss.37-40, 2004 (SCI-Expanded) identifier identifier identifier

41. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B.
ACTA PSYCHIATRICA SCANDINAVICA , cilt.108, sa.3, ss.208-214, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

42. An open clinical trial of reboxetine in the treatment of social phobia

Atmaca M., Tezcan E., Kuloglu M. M.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.23, sa.4, ss.417-419, 2003 (SCI-Expanded) identifier identifier identifier

43. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.18, sa.6, ss.457-461, 2003 (SCI-Expanded) identifier identifier identifier

44. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

Atmaca M., Kuloglu M. M., Tezcan E., Buyukbayram A.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.18, sa.4, ss.277-280, 2003 (SCI-Expanded) Creative Commons License identifier identifier identifier

45. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B.
JOURNAL OF CLINICAL PSYCHIATRY , cilt.64, sa.5, ss.598-604, 2003 (SCI-Expanded) identifier identifier identifier

46. Free radicals in patients with post-traumatic stress disorder

Tezcan E., Atmaca M., Kuloglu M. M., Ustundag B.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.253, sa.2, ss.89-91, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

47. Serum leptin levels in patients with premature ejaculation before and after citalopram treatment

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B., Semercioz A.
BJU INTERNATIONAL , cilt.91, sa.3, ss.252-254, 2003 (SCI-Expanded) identifier identifier identifier

48. Neopterin production in posttraumatic stress disorder before and after pharmacotherapy

Atmaca M., Tezcan E., Kuloglu M. M., Onal S.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.253, sa.1, ss.34-36, 2003 (SCI-Expanded) identifier identifier identifier

49. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study

Atmaca M., Kuloglu M. M., Tezcan E., Semercioz A.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH , cilt.14, sa.6, ss.502-505, 2002 (SCI-Expanded) Creative Commons License identifier identifier identifier

50. Sildenafil use in patients with olanzapine-induced erectile dysfunction

Atmaca M., Kuloglu M. M., Tezcan E.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH , cilt.14, sa.6, ss.547-549, 2002 (SCI-Expanded) Creative Commons License identifier identifier identifier

51. Efficacy of citalopram and moclobemide in patients with social phobia: Some preliminary findings

Atmaca M., Kuloglu M. M., Tezcan E., Unal A.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.17, sa.8, ss.401-405, 2002 (SCI-Expanded) identifier identifier identifier

52. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia

Atmaca M., Kuloglu M. M., Buyukbayram A., Tezcan E.
EUROPEAN PSYCHIATRY , cilt.17, sa.5, ss.292-293, 2002 (SCI-Expanded) identifier identifier identifier

53. Serum leptin levels in patients with premature ejaculation

Atmaca M., Kuloglu M. M., Tezcan E., Semercioz A., Ustundag B., Ayar A.
ARCHIVES OF ANDROLOGY , cilt.48, sa.5, ss.345-350, 2002 (SCI-Expanded) Creative Commons License identifier identifier identifier

54. Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder

Atmaca M., Kuloglu M. M., Tezcan E., Onal S., Ustundag B.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.252, sa.4, ss.161-165, 2002 (SCI-Expanded) identifier identifier identifier

55. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

Kuloglu M. M., Ustundag B., Atmaca M., CANATAN H., Tezcan A., Cinkilinc N.
CELL BIOCHEMISTRY AND FUNCTION , cilt.20, sa.2, ss.171-175, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

56. "The detergent is circulating in my blood'': a case report

Atmaca M., Kuloglu M. M., Tezcan E., Unal A.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE , cilt.6, sa.2, ss.117-119, 2002 (SCI-Expanded) identifier identifier identifier

57. Bone metabolism and bone mineral density in premenopausal women with mild depression

kavuncu V., Kuloglu M. M., Kaya A., Sahin S., Atmaca M., Firidin B.
YONSEI MEDICAL JOURNAL , cilt.43, sa.1, ss.101-108, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

58. Serum leptin and cholesterol levels in patients with bipolar disorder

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B., Bayik Y.
NEUROPSYCHOBIOLOGY , cilt.46, sa.4, ss.176-179, 2002 (SCI-Expanded) identifier identifier identifier

59. Weight gain and serum leptin levels in patients on lithium treatment

Atmaca M., Kuloglu M. M., Tezcan E., Ustundag B.
NEUROPSYCHOBIOLOGY , cilt.46, sa.2, ss.67-69, 2002 (SCI-Expanded) identifier identifier identifier

60. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

Kuloglu M. M., Atmaca M., Tezcan E., Ustundag B., Bulut S.
NEUROPSYCHOBIOLOGY , cilt.46, sa.4, ss.186-189, 2002 (SCI-Expanded) identifier identifier identifier

61. Comparison of sociodemographic, clinical and phenomenological characteristics of Turkish and French patients suffering from obsessive-compulsive disorder

Millet B., Leclaire M., Bourdel M., Loo H., Tezcan E., Kuloglu M. M.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE , cilt.45, sa.9, ss.848, 2000 (SCI-Expanded) identifier identifier identifier
Diğer Dergilerde Yayınlanan Makaleler 8

1. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study

Dilbaz N., Kuloğlu M., Evren E. C., Paltun S. C., Bilici R., Noyan C. O., et al.
Substance Abuse: Research and Treatment , cilt.17, 2023 (ESCI) identifier identifier identifier

2. The relationship of serum leptin and ghrelin levels with craving and withdrawal in opioid use disorder

KARA H., ERDOĞAN A., Akbas H., KULOĞLU M. M.
Anadolu Psikiyatri Dergisi , cilt.22, sa.4, ss.200-205, 2021 (Scopus) identifier identifier

3. Tattooing and Its Relationship with Impulsivity in Substance Use Disorder Madde Kullanım Bozukluğunda Dövme Özellikleri ve Dövmenin Dürtüsellik ile İlişkisi

ERDOĞAN A., Kara H., KÖSE F., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.
Neuropsychiatric Investigation , cilt.59, sa.1, ss.1-7, 2021 (Scopus) identifier

4. Successful treatment with long-acting injectable aripiprazole monohydrate for two patients with dual diagnosis - substance use disorder and psychotic disorder

ERDOĞAN A., KULAKSIZOĞLU B., BİNGÖL M. S., CİNEMRE B., Kuloglu M. M.
Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.34, sa.1, ss.102-106, 2021 (ESCI) Creative Commons License identifier identifier

5. Madde Kullanım Bozukluğu Tedavisinde Bir Yıllık Tedavide Kalma Oranları: Geriye Dönük Bir Çalışma

KULAKSIZOĞLU B., BİNGÖL M. S., GÜLENGÖZ M., KULOĞLU M. M.
FIRAT TIP DERGİSİ , cilt.25, sa.1, ss.43-47, 2020 (Hakemli Dergi)

6. Personality, temperament traits and impulsivity levels in opiate use disorder patients with and without intravenous use İntravenöz kullanımı olan ve olmayan opiyat kullanım bozukluğu hastalarında kişilik, mizaç özellikleri ve dürtüsellik düzeyleri

ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.
Yeni Symposium , cilt.58, sa.3, ss.2-6, 2020 (Scopus) identifier

7. The Effect Of The Psychoeducatıon In The Psychıatrıc Day Hospıtal On The Selfeffıcacy And Well-Beıng Of The Patıents

KESER İ., ÇAYNAK S., ERGÜN G., SAKİNER A., KULOĞLU M. M.
JOURNAL OF PSYCHIATRIC NURSING , cilt.9, sa.1, ss.119-120, 2018 (Hakemli Dergi)

8. Psikiyatri Gündüz Hastanesinde Verilen Psikoeğitimin Hastaların Öz Yeterlilik ve İyilik Haline Etkisi The Effect Of The Psychoeducatıon In The Psychıatrıc Day Hospıtal On The Selfeffıcacy And Well-Beıng Of The Patıents

Keser İ., Çaynak S., Ergün G., Sakiner A., Kuloğlu M. M.
JOURNAL OF PSYCHIATRIC NURSING , cilt.9, sa.1, ss.119-120, 2018 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. 2013-2018 Yılları Arasında Bağımlılık Tedavisi Almak için Başvuran Hastaların Suç Profilleri

Uluyol F. M., Bayraktar S., Kuloğlu M. M.
1. Uluslararası 17. Ulusal Adli Bilimler Kongresi, Antalya, Türkiye, 12 - 15 Kasım 2020, ss.168, (Özet Bildiri) Sürdürülebilir Kalkınma

2. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.
22st ESCV (European Society for Clinical Virology), Copenhag, Danimarka, 10 - 14 Eylül 2019, ss.231, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.
22st ESCV (European Society for Clinical Virology), Copenhag, Danimarka, 10 - 14 Eylül 2019, ss.231, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.
22st ESCV (European Society for Clinical Virology), Copenhag, Danimarka, 10 - 14 Eylül 2019, ss.231, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. Psikiyatri Gündüz Hastanesinde Verilen Psikoeğitimin Hastaların Öz Yeterlilik ve İyilik Haline Etkisi

KESER İ., ÇAYNAK S., ERGÜN G., sakiner a., KULOĞLU M. M.
V.ULUSLARARASI IX.ULUSAL PSİKİYATRİ HEMŞİRELİĞİ KONGRESİ, Antalya, Türkiye, 20 - 23 Kasım 2018, ss.1902-1905, (Özet Bildiri)

6. Aripiprazole-induced allergy: case report

KARA H., DEMİREĞEN Ö., BALCI M. M., KULOĞLU M. M., TOMAR T.
10. Uluslararası Psikofarmakoloji Kongresi ve 6. Uluslararası Çocuk ve Ergen Psikofarmakolojisi Sempozyumu, Antalya, Türkiye, 25 - 29 Nisan 2018, cilt.2018:28, ss.140-141, (Tam Metin Bildiri)

7. Lamotrigine-induced Stevens-Johnson Syndrome

KARA H., DEMİREĞEN Ö., BALCI M. M., KULOĞLU M. M., TOMAR T.
10. Uluslararası Psikofarmakoloji Kongresi & 6. Uluslararası Çocuk ve Ergen Psikofarmakolojisi Sempozyumu, Antalya, Türkiye, 25 - 29 Nisan 2018, cilt.2018:28, ss.237-238, (Tam Metin Bildiri)

8. Codeine Content Drug Abuse and Alcohol Use Disorder: A Case Report

KARA H., BALCI M. M., KULOĞLU M. M.
9. Uluslararası Psikofarmakoloji Kongresi ve 5. Uluslararası Çocuk ve Ergen Psikofarmakolojisi Sempozyumu, Antalya, Türkiye, 26 - 30 Nisan 2017, cilt.2017:27, ss.106, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

9. BİR ÜNİVERSİTE HASTANESİ ALKOL VE MADDE BAĞIMLILIĞI ARAŞTIRMA VE UYGULAMA MERKEZİ NE BAŞVURAN HASTALARIN SOSYODEMOGRAFİK ÖZELLİKLERİ MADDE KULLANIM DURUMLARI VE TEDAVİYE ERİŞİMLERİ

BAŞAK G., ÖZDEMİR F., KULOĞLU M. M., DÖNMEZ L.
18.Ulusal Halk Sağlığı Kongresi, Türkiye, 5 - 09 Ekim 2015, ss.1107-1108 Sürdürülebilir Kalkınma
Metrikler

Yayın

78

Yayın (WoS)

64

Yayın (Scopus)

66

Atıf (WoS)

1448

H-İndeks (WoS)

21

Atıf (Scopus)

1697

H-İndeks (Scopus)

22

Proje

2

Açık Erişim

14
BM Sürdürülebilir Kalkınma Amaçları